Scientific Editor, RSNA (A.N.B.); Center for Infectious Disease Imaging, NIH Clinical Center, Bethesda, Maryland (D.A.H.); Departments of Pediatrics and Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan (J.B.W.); Division of Cardiothoracic Radiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan (P.A.); Department of Radiology, Division of Abdominal imaging, University of Michigan, Ann Arbor, Michigan (M.M.); Department of Radiology, Biomedical Engineering, and Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan (G.D.L).
Radiol Imaging Cancer. 2020 Nov 13;2(6):e200058. doi: 10.1148/rycan.2020200058. eCollection 2020 Nov.
Patients with cancer have been negatively impacted during the coronavirus disease 2019 (COVID-19) pandemic, as many of these individuals may be immunosuppressed and of older age. Additionally, cancer follow-up or imaging appointments have been delayed in many clinics around the world. Postponement of routine screening exams will result in delays in new cancer diagnoses. Clinics are continuing to monitor and adapt their appointment schedules based on local outbreaks of COVID-19. Studies on COVID-19 in patients with cancer are limited, but consistently indicate that this population is at risk for more severe COVID-19 illness. Data from recent studies also suggest that pediatric patients with cancer have a lower risk of severe COVID-19 illness compared to adults. Certain features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection detected by lung, brain, and gastrointestinal imaging may confound radiologists' interpretation of cancer diagnosis, staging, and treatment response. Lastly, as clinics begin to re-open for routine appointments, protocols have been put in place to reduce SARS-CoV-2 exposure to patients during their visits. This review details different perspectives on the impact of the COVID-19 pandemic on patients with cancer and on cancer imaging. Abdomen/GI, Cardiac, Infection, Nervous-Peripheral.
癌症患者在 2019 冠状病毒病（COVID-19）大流行期间受到负面影响，因为许多此类患者可能存在免疫抑制且年龄较大。此外，全球许多诊所的癌症随访或影像学预约都被推迟了。常规筛查检查的推迟将导致新癌症诊断的延迟。诊所继续根据当地 COVID-19 的爆发情况，监测和调整其预约时间表。关于癌症患者 COVID-19 的研究有限，但一致表明该人群患更严重 COVID-19 疾病的风险更高。来自最近研究的数据还表明，与成年人相比，患有癌症的儿科患者患严重 COVID-19 疾病的风险较低。肺部、大脑和胃肠道影像学检测到的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的某些特征可能会混淆放射科医生对癌症诊断、分期和治疗反应的解释。最后，随着诊所开始重新开放进行常规预约，已经制定了方案，以减少 SARS-CoV-2 在患者就诊期间对其的暴露。这篇综述详细介绍了 COVID-19 大流行对癌症患者和癌症影像学的不同影响。腹部/GI、心脏、感染、周围神经。
